Document is current
Any future updates will be listed below
-
Authors
Ayala-de Miguel, Carlos https://orcid.org/0009-0006-2897-1361
Jiménez-Castro, Jerónimo https://orcid.org/0000-0003-2618-1412
Sánchez-Vegas, Adrián
Díaz-López, Sebastián
Chaves-Conde, Manuel https://orcid.org/0000-0001-6412-5732
- License Information
-
More Information
Article History
Received: 19 August 2023
Accepted: 14 November 2023
First Online: 9 December 2023
Declarations
:
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: C. Ayala-de Miguel: Honoraria: LEO Pharma. Travel expenses/Congress Support: Pfizer, Novartis. J. Jiménez-Castro: Honoraria: Servier, Merck. Travel expenses/Congress Support: Amgen. S. Díaz-López: Travel expenses/Congress Support: Merck, Pfizer, LEO Pharma, IPSEN Pharma. M. Chaves-Conde: Honoraria: Merck. Travel expenses/Congress Support: Pfizer, MSD, Merck. A. Sánchez-Vegas: Honoraria: MSD, GSK y Pfizer. Travel expenses/Congress Support: GSK, Amgen.
: This article does not contain any studies with human participants performed by any of the authors.
: For this type of study, no informed consent is required.
